[HTML][HTML] Trends in stimulant prescription fills among commercially insured children and adults—United States, 2016–2021
ML Danielson - MMWR. Morbidity and mortality weekly report, 2023 - cdc.gov
Trends in Stimulant Prescription Fills Among Commercially Insured Children and Adults —
United States, 2016–2021 | MMWR Skip directly to site content Skip directly to search Español …
United States, 2016–2021 | MMWR Skip directly to site content Skip directly to search Español …
[HTML][HTML] Recent trends in prescription drug misuse in the United States by age, race/ethnicity, and sex
Methods Data were from the 2015–2019 National Survey on Drug Use and Health (N=
282,768), examining annualized PDM change by demographics. Results Opioid and poly …
282,768), examining annualized PDM change by demographics. Results Opioid and poly …
State-level estimates of the prevalence of parent-reported ADHD diagnosis and treatment among US children and adolescents, 2016 to 2019
ML Danielson, JR Holbrook, RH Bitsko… - Journal of attention …, 2022 - journals.sagepub.com
Objective: To provide state-level estimates of diagnosed ADHD and associated treatment
among children in the United States in 2016 to 2019. Method: This study used the National …
among children in the United States in 2016 to 2019. Method: This study used the National …
Dopamine receptor expression and the pathogenesis of attention-deficit hyperactivity disorder: a scoping review of the literature
R Dum, A Ghahramani, R Baweja, A Bellon - Current Developmental …, 2022 - Springer
Purpose of Review CNS stimulants have been the treatment of choice among children with
attention-deficit hyperactivity disorder (ADHD) ages 6 and older, but their effectiveness and …
attention-deficit hyperactivity disorder (ADHD) ages 6 and older, but their effectiveness and …
Trends in incident prescriptions for behavioral health medications in the US, 2018-2022
G Chai, J Xu, S Goyal, C Woods, A Ho, J Song… - JAMA …, 2024 - jamanetwork.com
Importance The COVID-19 pandemic reportedly increased behavioral health needs and
impacted treatment access. Objective To assess changes in incident prescriptions …
impacted treatment access. Objective To assess changes in incident prescriptions …
Extended-release viloxazine compared with atomoxetine for attention deficit hyperactivity disorder
MZ Price, RL Price - CNS drugs, 2023 - Springer
Abstract Background and Objective In our outpatient pediatric and adult psychiatry centers,
we reserve psychostimulants for predominantly inattentive attention deficit hyperactivity …
we reserve psychostimulants for predominantly inattentive attention deficit hyperactivity …
Is age of onset and duration of stimulant therapy for ADHD associated with cocaine, methamphetamine, and prescription stimulant misuse?
Background To assess whether age of onset and duration of stimulant therapy for attention‐
deficit/hyperactivity disorder (ADHD) are associated with cocaine, methamphetamine, and …
deficit/hyperactivity disorder (ADHD) are associated with cocaine, methamphetamine, and …
Trends in characteristics of the recipients of new prescription stimulants between years 2010 and 2020 in the United States: an observational cohort study
Background Stimulant prescriptions increased by 250% in the United States from 2006-2016
while diagnoses for ADHD minimally increased. There is insufficient data regarding who …
while diagnoses for ADHD minimally increased. There is insufficient data regarding who …
Patterns of attention deficit hyperactivity disorder medicine use in the era of new non-stimulant medicines: A population-based study among Australian children and …
Background and aims: New therapeutic options such as lisdexamfetamine and guanfacine
have recently become available for the treatment of attention deficit hyperactivity disorder …
have recently become available for the treatment of attention deficit hyperactivity disorder …
ADHD Prevalence among US children and adolescents in 2022: Diagnosis, severity, co-occurring disorders, and treatment
ML Danielson, AH Claussen, RH Bitsko… - Journal of Clinical …, 2024 - Taylor & Francis
Objective To provide updated national prevalence estimates of diagnosed attention-
deficit/hyperactivity disorder (ADHD), ADHD severity, co-occurring disorders, and receipt of …
deficit/hyperactivity disorder (ADHD), ADHD severity, co-occurring disorders, and receipt of …